A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objectives of this study are to characterize the pharmacodynamic profile, safety and
tolerability of ONO-5129 in patients with Type 2 Diabetes mellitus